Axsome

AXSM NASDAQ
24.85
-0.38
-1.51%
已收盘, 16:24 08/23 EDT
开盘
25.03
昨收
25.23
最高
25.63
最低
24.58
成交量
40.55万
成交均量(3M)
98.64万
52周最高
28.70
52周最低
1.940
换手率
1.18%
市值
8.53亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Axsome AXSM股票价格,Axsome股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02 (disodium zoledronate tetrahydrate), is an oral, targeted, non opioid therapeutic for chronic pain. It is developing AXS 02 for the treatment of pain in over three conditions, such as complex regional pain syndrome (CRPS); knee osteoarthritis (OA) associated with bone marrow lesions (BMLs), and chronic low back pain (CLBP), associated with type I, or mixed type I and type II Modic changes (MCs). Its product candidate, AXS 05, is a fixed dose combination of dextromethorphan (DM) and bupropion. It is developing AXS 05 for the treatment of over two conditions, such as treatment resistant depression (TRD), and agitation in patients with Alzheimer's disease (AD).
展开 >

最近浏览

名称
价格
涨跌幅